Does ACT work for chronic pain? What the evidence says.

A fair reading of the trials, without the hype in either direction.

People living with pain have been promised a lot. Every few years there is a new treatment that will fix everything, and most of them do not. So when we say ACT works, it is worth being specific about what “works” means, how confident the evidence lets us be, and what it does not do.

What has been studied

ACT for chronic pain has been tested in randomized controlled trials since the mid-2000s. Trials have included people with chronic low back pain, fibromyalgia, headache and migraine, arthritis, pelvic pain, and mixed chronic pain. Comparison groups have ranged from waiting lists and usual care to active treatments like CBT and pain education. Delivery has included individual therapy, groups, residential programs, internet courses, and smartphone apps.

By now there are dozens of trials and several meta-analyses pooling them. That is a reasonable evidence base, not an overwhelming one, and the quality of individual trials varies.

What the meta-analyses find

Function and interference. This is the headline. Across pooled trials, ACT improves physical function and reduces how much pain interferes with daily life, and this is where the effects are largest. A 2023 review in the Clinical Journal of Pain pooled 21 randomized trials with nearly two thousand participants and found a large effect on pain-related functioning at follow-up, larger than for any other outcome. Another 2023 meta-analysis reported a medium effect on physical function that held at follow-up. In practical terms that means a clearly noticeable difference between people who had ACT and those who did not.

Pain intensity. Smaller but real. Both 2023 reviews found small-to-medium reductions in pain intensity, somewhat smaller at follow-up. ACT does not primarily target pain intensity, so the fact that it moves at all is notable. The likely mechanism is that a calmer, less threatened nervous system produces less pain.

Mood and quality of life. Consistent improvements in depression, with medium-to-large effects, and smaller but reliable improvements in anxiety and quality of life. An earlier meta-analysis of eleven trials found the same pattern.

Process measures. Large effects on pain acceptance and psychological flexibility, which are the things ACT is designed to change. Importantly, the changes in these processes track the changes in outcomes, which is the pattern you would expect if the therapy works the way it claims to.

Durability. Gains are mostly maintained at three to six months and, in the trials that looked, beyond. Trial sequential analysis in the 2023 review suggested the pooled estimates are unlikely to be due to chance or to be overturned by future trials.

What guidelines say

The UK's National Institute for Health and Care Excellence published its guideline on chronic primary pain in 2021. It recommends considering ACT or CBT for people aged 16 and over, delivered by appropriately trained professionals. The committee noted that ACT improved quality of life and sleep and reduced pain and psychological distress, and that although the number of studies was modest, an economic evaluation found ACT cost-effective. It found no basis to prefer ACT over CBT or the reverse. We compare the two in ACT vs CBT.

Where the evidence is thinner

Honesty requires a few caveats.

• Online delivery works, with caveats. Internet-based ACT shows real benefits, and the 21-trial review found no significant difference between online and face-to-face formats. One other analysis found face-to-face produced larger effects on physical outcomes. Either way, dropout is higher online, and daily support between sessions seems to matter. More on online ACT here.
• Longer programs do better. Trials with more total contact time showed larger effects on nearly every outcome. Brief programs still beat controls, but there appears to be a dose effect.
• Some conditions respond more than others. Trials in people with a specific diagnosis, especially fibromyalgia, showed larger effects than those in mixed chronic pain, though all showed benefit.
• Trial quality varies. Many studies are small, and blinding is impossible in psychotherapy trials. Larger, higher-quality trials have generally found similar but somewhat smaller effects than early ones, which is a normal pattern.
• Head-to-head data are limited. ACT and CBT appear comparable, but direct comparisons are few.

What “works” means in practice

ACT does not make chronic pain go away for most people. What it reliably does is shrink the pain's footprint: more activity, better mood, better sleep, less of the day organized around avoidance. For some people pain intensity also drops. For many, the sentence they use afterward is some version of “the pain is still there, but I have my life back.”

That is a meaningful outcome, and it is the one the evidence supports.

Why we built Cindra around it

We chose ACT for Cindra because the evidence is solid, because its skills can be practiced in short daily conversations, and because the research suggests that practice between sessions is where online delivery falls short. Cindra is designed to close that gap. Its daily check-ins are not a replacement for a trained therapist. They are what happens on the other six days.

This article is for general education and is not medical advice. Chronic pain deserves a proper assessment. If your pain is new, changing, or comes with red-flag symptoms like numbness, weakness, fever, or loss of bladder or bowel control, see a clinician promptly.